Evidence map›Paper›PMID 37817778›Full record

ArticleComputational and structural biotechnology journal2023

W254 in furin functions as a molecular gate promoting anti-viral drug binding: Elucidation of putative drug tunneling and docking by non-equilibrium molecular dynamics.

Harry Ridgway, John D Orbell, Minos-Timotheos Matsoukas, Konstantinos Kelaidonis, Graham J Moore, Sotiris Tsiodras, Vasilis G Gorgoulis, Christos T Chasapis, Vasso Apostolopoulos, John M Matsoukas

Open access · goldAbstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Development and Prospects of Furin Inhibitors for Therapeutic Applications.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 4 countries.

Harry RidgwayInstitute for Sustainable Industries and Liveable Cities, Victoria University, Melbourne, VIC 8001, Australia.
John D OrbellInstitute for Sustainable Industries and Liveable Cities, Victoria University, Melbourne, VIC 8001, Australia.
Minos-Timotheos MatsoukasDepartment of Biomedical Engineering, University of West Attica, Athens 12243, Greece.
Konstantinos KelaidonisNewDrug/NeoFar PC, Patras Science Park, Patras 26504, Greece.
Graham J MoorePepmetics Inc., 772 Murphy Place, Victoria, BC V8Y 3H4, Canada.
Sotiris TsiodrasDepartment of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Vasilis G GorgoulisNinewells Hospital and Medical School, University of Dundee, Dundee, UK.
Christos T ChasapisInstitute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.
Vasso ApostolopoulosInstitute for Health and Sport, Immunology and Translational Research, Victoria University, Melbourne 3030, VIC, Australia.
John M MatsoukasNewDrug/NeoFar PC, Patras Science Park, Patras 26504, Greece.
University of Calgary · CAVictoria University · AUAustralian Institute for Musculoskeletal Science · AUDemocritus University of Thrace · GRNational and Kapodistrian University of Athens · GRNational Hellenic Research Foundation · GRUniversity of West Attica · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Furins are serine endoproteases that process precursor proteins into their biologically active forms, and they play essential roles in normal metabolism and disease presentation, including promoting expression of bacterial virulence factors and viral pathogenesis. Thus, furins represent vital targets for development of antimicrobial and antiviral therapeutics. Recent experimental evidence indicated that dichlorophenyl (DCP)-pyridine "BOS" drugs (

Indexed as

AntiviralFurinInduced-fit drug dockingInteractive molecular dynamicsSARS-CoV-2Therapeutics

Identifiers

PMID37817778
PMCPMC10561063
OpenAlexW4386580341

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.